Endogastric surgery for gastric diseases--simplifying technical aspects.

Surg Laparosc Endosc Percutan Tech

Surgery of the Alimentary Tract Division of the Department of Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil.

Published: October 2007

Minimally invasive surgery has become the preferred treatment strategy for most gastrointestinal diseases. Owing to specific anatomical reasons and in highly selected patients, gastric diseases offer the opportunity for an endogastric approach. In this setting, 2 different strategies may be used: (1) endogastric mucosectomy for superficial lesions such as highly selected early gastric cancer and (2) stapled wedge resection for intramural lesions such as gastric stromal tumors. A detailed description of this simple and radical treatment option is performed which requires standard laparoscopic instrumentation and basic laparoscopic skills. With the widespread of this approach, endogastric surgery is expected to become the preferred initial step in the management of various gastric diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLE.0b013e3180caa1f8DOI Listing

Publication Analysis

Top Keywords

endogastric surgery
8
highly selected
8
gastric diseases
8
gastric
5
endogastric
4
surgery gastric
4
gastric diseases--simplifying
4
diseases--simplifying technical
4
technical aspects
4
aspects minimally
4

Similar Publications

Background: Gastroesophageal reflux disease (GERD) is a common adverse effect after metabolic and bariatric surgery (MBS). Identifying patients with preexisting GERD is critical for preoperative planning. The American Foregut Society (AFS) recently proposed a new endoscopic classification system for objective assessment of the esophagogastric junction (EGJ) integrity, building upon the Hill classification.

View Article and Find Full Text PDF

Background: Leiomyomas are benign smooth muscle tumors found at the gastroesophageal junction (GEJ) ( Mathew G, Osueni A, Carter YM. Esophageal Leiomyoma. StatPearls.

View Article and Find Full Text PDF
Article Synopsis
  • Stent misdeployment (SMD) is a significant challenge in EUS-guided choledochoduodenostomy (EUS-CDS) for treating malignant distal biliary obstruction, with the study aiming to define its rate and outcomes, and propose a classification system.
  • In a review of data from two randomized controlled trials involving 152 patients, SMD was found in 7.2% of cases, with most types being misdeployments of the distal flange (type I) and a small number causing minor adverse events.
  • The analysis revealed that a smaller extrahepatic bile duct diameter (≤ 15 mm) increases the likelihood of SMD or technical failures, but most misdeployments can be successfully managed
View Article and Find Full Text PDF

Background And Aims: EUS-guided gastroenterostomy (EUS-GE) has emerged as an alternative to surgical gastrojejunostomy and endoluminal stenting for malignant gastric outlet obstruction (MGOO). Studies regarding factors associated with the EUS-GE outcomes are limited.

Methods: A retrospective observational study was conducted with consecutive patients who underwent EUS-GE for MGOO from January 2016 to November 2023.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!